FDA Approved: APTIOM — Original Application (Sumitomo Pharma America, Inc.)

View source ↗

Summary

FDA approved APTIOM (eslicarbazepine acetate) from Sumitomo Pharma America as an original NDA for use in adults with partial-onset seizures due to epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• APTIOM (Eslicarbazepine acetate)

Snippet

ORIG AP for APTIOM (ESLICARBAZEPINE ACETATE)